| 截至月份: | 2025年10月31日 | 狀態: 新提交 | | --- | --- | --- | | 致：香港交易及結算所有限公司 | | | | 公司名稱: | 滙盈控股有限公司 | | | 呈交日期: | 2025年11月5日 | | | I. 法定/註冊股本變動 | 不適用 | | 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 FF301 第 1 頁 共 10 頁 v 1.1.1 第 2 頁 共 10 頁 v 1.1.1 III.已發行股份及/或庫存股份變動詳情 (A). 股份期權（根據發行人的股份期權計劃） | 1. 股份分類 | | 普通股 | | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號(如上市) | | 00821 | | 說明 | | | | | | | | | 股份期權計劃詳情 | | 上月底結存的股份期權數 | | 本月內變動 | | 本月底結存的 ...

Group 1 - The company, 汇盈控股 (00821.HK), announced a rights issue based on a non-underwritten basis, offering 2 shares for every 1 existing share held as of the record date [1] - A total of 48.785 million ordinary shares will be issued on October 20, 2025, as part of this rights issue [1]

Core Viewpoint - Huaying Holdings (00821) announced the issuance of 48.7849 million shares based on a "1 for 2" rights issue scheduled for October 20, 2025 [1] Summary by Category - **Company Announcement** - The company will issue 48.7849 million shares as part of its rights issue [1] - The rights issue is based on a "1 for 2" ratio, indicating that for every 2 shares held, shareholders will have the right to purchase 1 additional share [1] - The issuance date is set for October 20, 2025 [1]

Core Points - The company, 汇盈控股 (00821), announced a rights issue based on a "1 for 2" ratio, issuing a total of 48.7849 million shares [1] Group 1 - The rights issue is scheduled for October 20, 2025 [1]

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 滙盈控股有限公司 呈交日期： 2025年10月20日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | | 是 | | | | 證券代號 (如上市) | 00821 | 說明 | | | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | | | | | | 事 ...

Core Viewpoint - The company, 汇盈控股 (00821), has announced that all conditions for its rights issue have been met, and the rights issue became unconditional on October 13, 2025 [1] Summary by Relevant Sections Rights Issue Acceptance - A total of 15 provisional allotment notices were received, resulting in valid acceptances for 43.7916 million shares, which is approximately 8.85% of the total 495 million shares available for subscription [1] - Additionally, 14 extra application forms were submitted for an additional 4.9933 million shares, accounting for about 1.01% of the total shares available for subscription [1] - The total number of valid acceptances and applications received was 29, involving 48.7849 million shares, representing approximately 9.86% of the total shares available for subscription [1] Proceeds from the Rights Issue - The total proceeds from the rights issue are approximately HKD 21.9532 million [1] Unsubscribed Shares - There are still 446 million shares available for subscription, which is about 90.14% of the total shares available for the rights issue [1]

Group 1 - The company announced that all conditions for the rights issue have been met, and the rights issue became unconditional on October 13, 2025 [1] - As of the final acceptance time on October 10, 2025, a total of 15 provisional allotment notices were received, resulting in valid acceptances for 43,791,595 shares, which is approximately 8.85% of the total 494,704,608 shares available for subscription [1] - Additionally, 14 extra application forms were received for a total of 4,993,320 shares, representing about 1.01% of the total shares available for subscription [1] Group 2 - The total valid acceptances and applications amounted to 29, involving 48,784,915 shares, which is approximately 9.86% of the total shares available for subscription [1] - The total proceeds from the rights issue are approximately HKD 21.95 million [1] - There are still 445,919,693 shares available for subscription, which is about 90.14% of the total shares [1] Group 3 - Due to insufficient subscriptions for the rights issue, the placement agent has conditionally agreed to act as the company's placement agent to facilitate the subscription of at least six subscribers for the unsold shares at a placement price of HKD 0.45 per share [2] - The placement period will commence on October 20, 2025, and will end on October 31, 2025, or a later date as agreed in writing between the company and the placement agent [2]

Core Viewpoint - Huiying Holdings (00821) has announced that all conditions for the rights issue have been met, and the rights issue became unconditional on October 13, 2025 [1] Summary by Sections Rights Issue Details - As of the final acceptance time on October 10, 2025, a total of 15 valid acceptance notices were received, involving 43.7916 million shares, which is approximately 8.85% of the total 495 million shares available for subscription [1] - Additionally, 14 valid applications for extra shares were received, involving 4.9933 million shares, accounting for about 1.01% of the total shares available for subscription [1] - The total number of valid acceptances and applications received was 29, involving 48.7849 million shares, which is about 9.86% of the total shares available for subscription [1] Financial Implications - The total proceeds from the rights issue are approximately HKD 21.9532 million [1] - There are still 446 million shares available for subscription, which is about 90.14% of the total shares available for subscription [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈之內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示，概不會就因本公佈全部或 任何部分內容而產生或因倚賴該等內容而引起之任何損失承擔任何責任。 滙盈控股有限公司 （於香港註冊成立之有限公司） （股票代號：821） 網址：http://www.vcgroup.com.hk (1)按於記錄日期 每持有一(1)股現有股份獲發兩(2)股供股股份之 非包銷基準進行供股之結果； (2)開始配售配售股份； 及 (3)對尚未行使購股權及可換股債券之調整 謹此提述(i)滙盈控股有限公司（「本公司」）日期為二零二五年八月二十六日之通函； (ii)本公司日期為二零二五年九月十一日之投票結果公佈；及(iii)本公司日期為二 零二五年九月二十四日之供股章程（「供股章程」），內容有關（其中包括）供股及配 售事項。除文義另有所指外，本公佈所用詞彙與供股章程所界定者具有相同涵義。 供股之結果 開始買賣繳足股款供股股份 預期繳足股款供股股份將於二零二五年十月二十一日（星期二）上午九時正在聯交 所開始買賣。 2 對本公司股權架構之影響 據董事經作出一切合理查詢後所知、所悉及所信 ...

Major Events - Huiying Holdings (00821) plans to establish a joint venture to provide training, professional consulting services, and high-end conference business in the RWA category [1] - MIRXES-B (02629) intends to set up a joint venture for research, development, and commercialization of early cancer detection and other nucleic acid-based tests in Malaysia [1] - Kintor Pharmaceutical-B (02171) will present updates on the research results of CT0596 at the 2025 ASH annual meeting [1] - Energy & Energy Global (01142) has had its mining license revoked by a Russian subsidiary and plans to appeal further [1] Operating Performance - C&D International Group (01908) reported a cumulative contract sales amount of approximately 71.03 billion yuan for the first nine months, representing a year-on-year increase of about 7.5% [1] - Sa Sa International (00178) recorded a total revenue of 1.031 billion HKD for the second quarter, an annual increase of 8.4% [1] Buybacks/Reductions - Hang Seng Bank (00011) repurchased 200,000 shares for 23.9836 million HKD on October 6 [1] - Tencent Holdings (00700) repurchased 815,000 shares for 550.3 million HKD on October 6 [1] - Mengniu Dairy (02319) repurchased 1 million shares for 14.4099 million HKD on October 6 [1] - HSBC Holdings (00005) repurchased 1.49 million shares for 163 million HKD on October 3 [1]